Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study

OBJECTIVE: To assess changes in work productivity in patients who have achieved response using etanercept (ETN) 50 mg+methotrexate (MTX) (phase I) are randomised to ETN 25 mg+MTX versus MTX versus placebo (phase II) and then withdrawn from treatment (phase III). METHODS: Patients included in the ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Bansback, Nick, Sun, Huiying, Pedersen, Ronald, Kotak, Sameer, Anis, Aslam H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947791/
https://www.ncbi.nlm.nih.gov/pubmed/27486524
http://dx.doi.org/10.1136/rmdopen-2015-000222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947791/
https://www.ncbi.nlm.nih.gov/pubmed/27486524
http://dx.doi.org/10.1136/rmdopen-2015-000222

Ejemplares similares